Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for T-cell and NK-cell neoplasm has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
232 publications have been identified in PubMed for T-cell and NK-cell neoplasm. Kisho has analyzed 149 by research type. Research spans Basic Science / Preclinical (47%), Review / Meta-Analysis (23%), and Gene Therapy / Novel Therapeutics (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 70 |
Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 12:24 PM UTC
47%
Research summaries | 35 | 23% |
New treatment approaches | 27 | 18% |
Clinical study results | 6 | 4% |
Disease patterns and progression | 5 | 3% |
Other research | 2 | 1% |
Testing and diagnosis research | 2 | 1% |
Patient case studies | 2 | 1% |
Fan Y (2026). [PMID: 40659834](https://pubmed.ncbi.nlm.nih.gov/40659834/). *Nat Biomed Eng*. [Basic Science / Preclinical]
Zhang C (2026). [PMID: 41961946](https://pubmed.ncbi.nlm.nih.gov/41961946/). *Sci Immunol*. [Basic Science / Preclinical]
Terasaki A (2026). [PMID: 41529696](https://pubmed.ncbi.nlm.nih.gov/41529696/). *Cell Metab*. [Basic Science / Preclinical]
Musa H (2026). [PMID: 40874339](https://pubmed.ncbi.nlm.nih.gov/40874339/). *Haematologica*. [Clinical Trial Publication]
Priem B (2026). [PMID: 41477842](https://pubmed.ncbi.nlm.nih.gov/41477842/). *Sci Adv*. [Gene Therapy / Novel Therapeutics]
Kim YM (2026). [PMID: 41872506](https://pubmed.ncbi.nlm.nih.gov/41872506/). *Nat Immunol*. [Gene Therapy / Novel Therapeutics]
Guerra L (2026). [PMID: 41734064](https://pubmed.ncbi.nlm.nih.gov/41734064/). *Cell Rep*. [Basic Science / Preclinical]
Azani A (2026). [PMID: 41455063](https://pubmed.ncbi.nlm.nih.gov/41455063/). *Stem Cell Rev Rep*. [Review / Meta-Analysis]
Penter L (2026). [PMID: 41026928](https://pubmed.ncbi.nlm.nih.gov/41026928/). *Blood*. [Basic Science / Preclinical]
Sato Y (2026). [PMID: 41510998](https://pubmed.ncbi.nlm.nih.gov/41510998/). *J Med Virol*. [Review / Meta-Analysis]